Ï㽶ÊÓƵ

News

Experts: Alzheimer’s disease

Published: 18 January 2018

. McGill and its affiliated institutions have experts in the following areas of Alzheimer’s detection and treatment who are available to comment:

Ìý

Canadian Consortium on Neurodegeneration in Aging (CCNA)) based at the ÌýJewish General Hospital:Ìý

Early detection of AD through genetic and cognitive markers

, Canada Research Chair in Early Detection of Alzheimer's Disease, Dept. of Psychiatry, Ï㽶ÊÓƵ

Searching for genetic or cognitive markers for identifying individuals at the preclinical stage of AD.

sylvia.villeneuve [at] mcgill.ca (French, English)

Ìý

Non-invasive early detection of AD (including by using AI)

, Researcher, Douglas Mental Health University Institute, Dept. of Psychiatry, Ï㽶ÊÓƵ

Christine Tardif, Depts. of Neurology and Neurosurgery & Bioengineering, Ï㽶ÊÓƵ

How AI can be used to predict individuals at greatest risk of decline up to 3 years before the decline occurs (paper under review)

Press release with more details;

mallar.chakravarty [at] douglas.mcgill.ca (English, French) - Work: 514-761-6131 x4753 or cell 514-754-4407.

christine.tardif [at] mcgill.ca (English, French)

Ìý

New mechanism detected in Alzheimer’s disease

Hamed Najafabadi, Dept. of Human Genetics, Ï㽶ÊÓƵ

Rate of Ï㽶ÊÓƵ decay could be a key to breakdown in communication between neurons

Press release with more details; V

hamed.najafabadi [at] mcgill.ca (English)

Ìý

Genetic aspects of AD

, Dept. of Psychiatry and Medicine – Ï㽶ÊÓƵ, Senior Researcher, Institute on Aging, Douglas Mental Health University Institute.

judes.poirier [at] mcgill.ca (English, French)

Ìý

Healthy carriers of the Alzheimer’s gene

Veronique Bohbot, Researcher, Douglas Mental Health University Institute & Dept. of Psychiatry, Ï㽶ÊÓƵ

New method makes it possible to identify people at lowest risk for developing the disease

veronique.bohbot [at] mcgill.ca

Ìý

Early detection of AD (including through smell tests):

, Research scientist, Director, Centre for Studies on Prevention of Alzheimer's DiseaseÌý

Press release with more details

john.breitner [at] douglas.mcgill.ca (English)

Back to top